Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vorapaxar in Japanese Subjects with Cerebral Infarction
NCT00684515Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Sep 2006
- Primary completion
- Nov 2007
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of vorapaxar in cerebral infarction, sponsored by Merck & Co.. Started Sep 2006; status: completed.
02
Drugs
vorapaxar
03
Conditions
cerebral infarction
Beyond the preview
Go deeper on NCT00684515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00684515.